tiprankstipranks
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
US Market

BioStem Technologies (BSEM) Income Statement

Compare
180 Followers

BioStem Technologies Income Statement

Last quarter (Q3 2024), BioStem Technologies's total revenue was $82.56M, an increase of 2193.84% from the same quarter last year. In Q3, BioStem Technologies's net income was $6.82M. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 16.69M$ 6.88M$ 4.34M$ 2.52M$ 2.63M
Gross Profit
$ 15.42M$ 5.99M$ 2.87M$ 1.25M$ 1.31M
Operating Expenses
$ 23.20M$ 10.67M$ 4.47M$ 3.09M$ 7.04M
Depreciation and Amortization
$ 229.02K$ 243.42K$ 283.90K$ 268.58K$ 334.12K
EBITDA
$ -7.55M$ -6.52M$ -602.00K$ -1.59M$ -5.38M
Operating Income
$ -7.78M$ -4.68M$ -1.61M$ -1.84M$ -5.73M
Other Income/Expenses
$ -704.01K$ -2.43M$ 193.93K$ -526.97K$ -619.20K
Pretax Income
$ -8.48M$ -7.11M$ -1.41M$ -2.37M$ -6.35M
Net Income
$ -8.48M$ -7.07M$ -1.45M$ -2.39M$ -6.38M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.62$ -0.62$ -0.12$ -0.26$ -0.69
Diluted EPS
$ -0.62$ -0.62$ -0.12$ -0.26$ -0.69
Weighted Average Shares Outstanding
13.71M 11.41M 11.69M 9.18M 9.25M
Weighted Average Shares Outstanding (Diluted)
13.71M 11.41M 11.69M 9.18M 9.25M
Currency in USD

BioStem Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis